AKEEGA Study for Prostate Cancer Patients

Have you or a loved one been diagnosed with metastatic prostate cancer?
A treatment called niraparib + abiraterone acetate (AKEEGA®) is currently under review for funding in Canada. As part of this process, we are inviting individuals affected by metastatic prostate cancer to share their experiences.
Patient perspectives play an important role in helping decision-makers better understand the real-world impact of cancer and its treatments.
If this applies to you or someone you care for, we encourage you to participate through this survey: https://bit.ly/3NXFFxq or through a one-on-one interview with Austin. ?+1 778-823-6687 ?